This menu provides the list of EV proteins identified by high-throughput analyses.
Refresh all contents
Search:
Dataset accession
UniProt accession
UniProt name
Protein name
Gene symbol
Species
Orthologous group
Superdomain:
All
Prokaryote
Eukaryote
Filter datasets:
- "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
- "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).
By species
Canis lupus familiaris
Homo sapiens
Mus musculus
In vitro/In vivo
Ex vivo
In vitro
In vivo
By sample type
Amniotic fluid
Aqueous humor of age-related macular degeneration
B cell (MM.1R)
B cell (MM.1S)
B cell (RN (HLA-DR15))
B cell (RPMI 8226)
Bladder cancer cell (HT1376)
Bladder cancer cell (UMUC-3, J82, SW780)
Blood
Bone marrow aspirate
Bone marrow-derived mesenchymal stem cell (MSC)
Brain
Breast cancer cell (MCF-7)
Breast cancer cell (MDA-MB-231)
Bronchial epithelial cell (BEAS2B)
Carotid atherosclerotic plaque
Cerebral microvascular endothelial cell (hCMEC/D3)
Cerebrospinal fluid
Cervical cancer (HeLa)
Choriocarcinoma cell (JEG3)
Chronic B-cell
Chronic lymphoid leukemia cell (JVM-3)
Chronic lymphoid leukemia cell (MEC-1)
Chronic myeloid leukemia (K562)
Colon cancer cell (LIM1863)
Colon cancer cell (SW480)
Colorectal cancer cell (HT29)
Colorectal cancer cell (LIM1215)
Colorectal cancer cell (LIM1863)
Colorectal cancer cell (SW480)
Colorectal cancer cell (SW620)
Colorectal cancer cells (HCT116, DLD1, SW480, SW620)
Dendritic cell
Dermal fibroblast (HDF)
Duodenal cancer cell (AZ-521)
Embryonic kidney cell (293T)
Embryonic kidney cell (HEK293)
Embryonic kidney cell (HEK293T)
Embryonic stem cell derived mesenchymal stem cell
Endothelial cell (HMEC-1)
Endothelial cell (HUVEC)
Endothelial progenitor cell
Epididymal fluid
Epithelial ovarian carcinoma cell (OVCAR3, OVCAR433, OVCAR5 , SKOV3)
Erythrocyte
Expressed prostatic secretions in urine
Extravillous trophoblast cell (HTR8/SVneo)
Fibroblast (CAF19)
Fibroblast (NIH-3T3)
Foreskin fibroblasts
Glioblastoma cell (U87)
Hepatic stellate cell
Hepatocellular carcinoma cell (97H)
Hepatocellular carcinoma cell (Hep3B)
Hepatocellular carcinoma cell (Huh7)
Hepatocellular carcinoma cell (LM3)
Human umbilical vascular endothelial cells
Keratinocyte
Kidney epithelial cell (MDCK)
Leukopak
Lung epithelial cell (E10)
Mammary epithelial cell (MCF10A)
Mammary luminal epithelial cell (C5.2)
Mammary luminal epithelial cell (HB4a)
Medulloblastoma cell (D283MED)
Melanoma cell (1205Lu)
Melanoma cell (501mel)
Melanoma cell (A375M)
Melanoma cell (B16-F10, SK-MEL-202, SK-MEL035, SK-MEL-265)
Melanoma cell (Daju)
Melanoma cell (G1)
Melanoma cell (MNT-1)
Melanoma cell (SKMEL28)
Monocyte (THP-1)
Monocyte-derived macrophage
Monocyte-derived macrophages
Nasal lavage
Neuroblastoma cell (CHLA255)
Neuroblastoma cell (HTLA-230)
Neuroblastoma cell (IGR-N91)
Neuroblastoma cell (IGR-NB8)
Neuroblastoma cell (IMR32)
Neuroblastoma cell (LAN-1)
Neuroblastoma cell (SH-SY5Y)
Neuroblastoma cell (SKNBe2c)
Neutrophil
Non small cell lung cancer (A549)
Non small cell lung cancer (HCC827)
Normal B cell (BJAB)
Normal bronchial epithelial cell (HBE4)
Oral squamous cell carcinoma cell (BHY)
Osteosarcoma (KHOS)
Osteosarcoma cell (MG63)
Osteosarcoma cell (SAOS-2)
Osteosarcoma cell (U2OS)
Ovarian cancer (HO-8910PM)
Ovarian cancer (OVCA429)
Pancreatic ductal adenocarcinoma cell (MiaPaCa2)
Pancreatic ductal adenocarcinoma cell (PATC43)
Pancreatic ductal adenocarcinoma cell (PATC66)
Pancreatic ductal adenocarcinoma cell (PATC92)
Pancreatic ductal adenocarcinoma cell (Pa01C)
Pancreatic ductal adenocarcinoma cell (Pa02C)
Pancreatic ductal adenocarcinoma cell (Pa03C)
Pancreatic ductal adenocarcinoma cell (Pa04C)
Pancreatic ductal adenocarcinoma cell (Pa07C)
Pancreatic ductal adenocarcinoma cell (Pa08C)
Pancreatic ductal adenocarcinoma cell (Pa09C)
Pancreatic ductal adenocarcinoma cell (Pa21C)
Pancreatic ductal adenocarcinoma cell (Pa28C)
Pancreatic ductal epithelial cell (HPNE)
Pericardial fluid
Peritoneal dialysis effluent
Placental mesenchymal stem cell
Placental villous tissue
Plasma
Platelet
Platelet-poor plasma
Primary chronic lymphoid leukemia cell #1
Primary chronic lymphoid leukemia cell #2
Prostate cancer cell (DU145)
Prostate cancer cell (DuCaP)
Prostate cancer cell (LNCaP)
Prostate cancer cell (PC-3)
Prostate cancer cell (PC3)
Pulmonary artery endothlelial cell (HPAEC)
Red blood cell
Retinal epithelial cell (ARPE-19)
Retinal pigment epithelial cell (RPE-1)
Retinal pigment epithelium cell (ARPE-19)
Saliva
Seminal plasma
Serum
Synovial fluid
T cell (Jurkat)
T cell blasts
T cells (C8166-45)
T cells (CEM-T4)
T cells (ED40515(-))
T cells (MT2)
T-lymphocytic cell
Tabecular meshwork cell
Thymus
Trophoblast cell (Sw71)
Urinary bladder transitional cell carcinoma (FL3)
Urinary bladder transitional cell carcinoma (SLT4)
Urinary bladder transitional cell carcinoma (T24)
Urine
Whole blood
By sample status
100K population
20K population
Activated_exosomes
Androgen-deprived
Antibody-mediated rejection
Apoptotic_exosomes
Apoptotic_microvesicles
Breast cancer-bronchiectasis non-tuberculosis Mycobacterium-infected
Bronchiectasis non-tuberculosis Mycobacterium-infected
CD63-CRISPR
CHAPS-treated
Cell-mediated rejection
Centrifugation
Control
Control_exosomes
Control_microvesicles
Curcumin-treated
DTT-treated
Deoxyelephantopin (DET)-treated
Deoxyelephantopin derivative-35 (DETD-35)-treated
Diabetic nephropathy
Differential centrifugation_Exosomes
Differential centrifugation_Microvesicles
Dihydrotestosterone-treated
Docetaxel-resistant
Docetaxel-sensitive
Donor 1 (Exo-Spin)
Donor 1 (SEC fraction 11)
Donor 1 (SEC fraction 7+8)
Donor 1 (SEC fraction 9+10)
Donor 2 (Exo-Spin)
Donor 2 (SEC fraction 9)
Donor 3 (Exo-Spin)
Donor 3 (SEC fraction 8)
Doxorubicin-treated
Ectosome
Exosome
Exosomes
F3-100K
F3-10K
F5-100K
F5-10K
HTLV-1-infected, Tax-negative
HTLV-1-infected, with producing high levels of infectious virus
HTLV-1-infected, without producing infectious virus
Healthy
Helicobacter pylori-infected
High-grade bladder cancer
High-risk prostate cancer (Gleason score 8-9)
Highly metastatic clone implanted in mice
Hypertensive patients under chronic suppression of RAS
Hypoxic condition
IL3-Lamp2b-transfected
Idiopathic focal segmental glomerulosclerosis
Idiopathic longitudinally extensive transverse myelitis
Idiopathic membranous nephropathy
Influenza A virus-infected
Insulin-induced
Irradiated (6 Gy)
Juvenile idiopathic arthritis (JIA)
LPS-treated
Lacunar infarction-cognitive decline without recurrent vascular events
Lacunar infarction-no adverse outcome
Lacunar infarction-recurrent vascular events
Low-grade prostate cancer patient
Low-risk prostate cancer (Gleason score 6)
Lung cancer_affinity chromatography coupled with filter system
M. tuberculosis-infected
Microvesicle, Storage day 21
Microvesicle, Storage day 3
Microvesicle, Storage day 42
Microvesicles
Multiple myeloma
Multiple sclerosis
Mycobacterium tuberculosis-infected_Orbitrap
Mycobacterium tuberculosis-infected_QSTAR
Myocardial infarction
Nanovesicle, Storage day 21
Nanovesicle, Storage day 3
Nanovesicle, Storage day 42
Neuromyelitis optica
Non-specific findings
Normal
Normal donors
Normal_A33 affinity purified exosomes
Normal_Annexin V-binding EVs
Normal_Cholera toxin part B-binding EVs
Normal_Density gradient
Normal_Density gradient ultracentrifufation based protocol
Normal_EpCAM affinity purification based protocol
Normal_EpCAM affinity purified exosomes
Normal_Orbitrap
Normal_QSTAR
Normal_Ultracentrifugation
Normal_affinity chromatography coupled with filter system
Normal_conventional method
Normal_shed vesicles
Osteoarthritis (OA)
P. falciparum-infected
PDGF-BB-treated
PEG precipitation
Parkinson's disease patient
Patients of autosomal recessive polycystic kidney disease
Patients of basement membrane nephropathy
Patients of carotid atherosclerosis
Patients of early IgA nephropathy
Patients of external counterpulsation therapy
Preeclampsia patients
Preeclampsia_Annexin V-binding EVs
Protein organic solvent precipitation
Radiation
Renal cell carcinoma patient
Rheumatoid arthritis (RA)
ST-eleavated myocardial infarction
Sequential centrifugal ultrafiltration_Exosomes
Sequential centrifugal ultrafiltration_Microvesicles
Serum-starved
Size exclusion chromatography
Stimulated by P-selectin-Ig
Stimulated in fluid phase
Stimulated in immobile phase
Stimulated with beta-glucan
Stressed (hypoxia, TNF-慣-induced activation, high glucose and mannose concentrations)
T. cruzi (metacyclic trypomastigote stage)-treated
T. gondii-infected
TGF-β-treated
Trauma patients
Treated by PAI-1
Treated by TNF-alpha
Treated by actinomycin D
Treated by phytohemagglutinin
Tubular injury
Ultra-cushion
Ultracentrifugation
Ultrafiltration-size exclusion chromatography
Number of molecules in one page:
100
200
All
The downloaded CSV file is not exactly the same as the displayed table. Opening CSV file with Excel can impair its content.
Protein name
UniProt accession
Publication
Orthologous group
Identification count
All / Prokaryote / Eukaryote
Serum albumin
P02768
Identification and proteomic profiling of exosomes in human urine.
Proc Natl Acad Sci U S A. 2004 Sep 7;101(36):13368-73. Epub 2004 Aug 23.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
The platelet microparticle proteome.
J Proteome Res. 2005 Sep-Oct;4(5):1516-21.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Proteomic analysis of malignant lymphocyte membrane microparticles using double ionization coverage optimization.
Proteomics. 2006 Jan;6(1):153-71.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Proteomic analysis of malignant lymphocyte membrane microparticles using double ionization coverage optimization.
Proteomics. 2006 Jan;6(1):153-71.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Proteomic analysis of malignant lymphocyte membrane microparticles using double ionization coverage optimization.
Proteomics. 2006 Jan;6(1):153-71.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Proteomic analysis of microvesicles derived from human colorectal cancer cells.
J Proteome Res. 2007 Dec;6(12):4646-55. Epub 2007 Oct 24.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
The proteome of red cell membranes and vesicles during storage in blood bank conditions.
Transfusion. 2008 May;48(5):827-35.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
The proteome of red cell membranes and vesicles during storage in blood bank conditions.
Transfusion. 2008 May;48(5):827-35.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
The proteome of red cell membranes and vesicles during storage in blood bank conditions.
Transfusion. 2008 May;48(5):827-35.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
The proteome of red cell membranes and vesicles during storage in blood bank conditions.
Transfusion. 2008 May;48(5):827-35.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
The proteome of red cell membranes and vesicles during storage in blood bank conditions.
Transfusion. 2008 May;48(5):827-35.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
The proteome of red cell membranes and vesicles during storage in blood bank conditions.
Transfusion. 2008 May;48(5):827-35.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Protein composition of human epididymosomes collected during surgical vasectomy reversal: a proteomic and genomic approach.
Hum Reprod. 2008 Aug;23(8):1698-707. doi: 10.1093/humrep/den181. Epub 2008 May 14.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Comparative proteomic analysis of PAI-1 and TNF-alpha-derived endothelial microparticles.
Proteomics. 2008 Jun;8(12):2430-46. doi: 10.1002/pmic.200701029.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Comparative proteomic analysis of PAI-1 and TNF-alpha-derived endothelial microparticles.
Proteomics. 2008 Jun;8(12):2430-46. doi: 10.1002/pmic.200701029.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Comparative proteomic analysis of PAI-1 and TNF-alpha-derived endothelial microparticles.
Proteomics. 2008 Jun;8(12):2430-46. doi: 10.1002/pmic.200701029.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Proteomic profiling of human plasma exosomes identifies PPARgamma as an exosome-associated protein.
Biochem Biophys Res Commun. 2009 Jan 16;378(3):433-8. doi: 10.1016/j.bbrc.2008.11.050. Epub 2008 Nov 24.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Large-scale proteomics and phosphoproteomics of urinary exosomes.
J Am Soc Nephrol. 2009 Feb;20(2):363-79. doi: 10.1681/ASN.2008040406. Epub 2008 Dec 3.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Characterization of PKD protein-positive exosome-like vesicles.
J Am Soc Nephrol. 2009 Feb;20(2):278-88. doi: 10.1681/ASN.2008060564. Epub 2009 Jan 21.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Proteomic analysis reveals presence of platelet microparticles in endothelial progenitor cell cultures.
Blood. 2009 Jul 16;114(3):723-32. doi: 10.1182/blood-2009-02-205930. Epub 2009 Apr 15.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Differential stimulation of monocytic cells results in distinct populations of microparticles.
J Thromb Haemost. 2009 Jun;7(6):1019-28. doi: 10.1111/j.1538-7836.2009.03434.x.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Proteomics characterization of cell membrane blebs in human retinal pigment epithelium cells.
Mol Cell Proteomics. 2009 Oct;8(10):2201-11. doi: 10.1074/mcp.M900203-MCP200. Epub 2009 Jun 29.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Proteomic and functional characterisation of platelet microparticle size classes.
Thromb Haemost. 2009 Oct;102(4):711-8. doi: 10.1160/TH09-04-243.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Proteomics, metabolomics, and immunomics on microparticles derived from human atherosclerotic plaques.
Circ Cardiovasc Genet. 2009 Aug;2(4):379-88. doi: 10.1161/CIRCGENETICS.108.842849. Epub 2009 May 14.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Proteomics analysis of bladder cancer exosomes.
Mol Cell Proteomics. 2010 Jun;9(6):1324-38. doi: 10.1074/mcp.M000063-MCP201. Epub 2010 Mar 11.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
MHC class II-associated proteins in B-cell exosomes and potential functional implications for exosome biogenesis.
Immunol Cell Biol. 2010 Nov-Dec;88(8):851-6. doi: 10.1038/icb.2010.64. Epub 2010 May 11.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival.
J Neurosci. 2010 May 19;30(20):6838-51. doi: 10.1523/JNEUROSCI.5699-09.2010.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Microfiltration isolation of human urinary exosomes for characterization by MS.
Proteomics Clin Appl. 2010 Jan;4(1):84-96. doi: 10.1002/prca.200800093. Epub 2009 Nov 11.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Morphologic and proteomic characterization of exosomes released by cultured extravillous trophoblast cells.
Exp Cell Res. 2011 May 1;317(8):1192-202. doi: 10.1016/j.yexcr.2011.01.014. Epub 2011 Jan 26.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Protein profile of exosomes from trabecular meshwork cells.
J Proteomics. 2011 May 16;74(6):796-804. doi: 10.1016/j.jprot.2011.02.024. Epub 2011 Mar 8.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Proteomic analysis of urinary exosomes from patients of early IgA nephropathy and thin basement membrane nephropathy.
Proteomics. 2011 Jun;11(12):2459-75. doi: 10.1002/pmic.201000443. Epub 2011 May 18.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Proteomic analysis of urinary exosomes from patients of early IgA nephropathy and thin basement membrane nephropathy.
Proteomics. 2011 Jun;11(12):2459-75. doi: 10.1002/pmic.201000443. Epub 2011 May 18.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Proteomic analysis of urinary exosomes from patients of early IgA nephropathy and thin basement membrane nephropathy.
Proteomics. 2011 Jun;11(12):2459-75. doi: 10.1002/pmic.201000443. Epub 2011 May 18.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Expression of PTRF in PC-3 Cells modulates cholesterol dynamics and the actin cytoskeleton impacting secretion pathways.
Mol Cell Proteomics. 2012 Feb;11(2):M111.012245. doi: 10.1074/mcp.M111.012245. Epub 2011 Oct 26.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Proteomic analysis of urine exosomes by multidimensional protein identification technology (MudPIT).
Proteomics. 2012 Jan;12(2):329-38. doi: 10.1002/pmic.201100477. Epub 2011 Dec 16.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
The protein interaction network of extracellular vesicles derived from human colorectal cancer cells.
J Proteome Res. 2012 Feb 3;11(2):1144-51. doi: 10.1021/pr200842h. Epub 2012 Jan 9.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes.
Methods. 2012 Feb;56(2):293-304. doi: 10.1016/j.ymeth.2012.01.002. Epub 2012 Jan 21.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes.
Methods. 2012 Feb;56(2):293-304. doi: 10.1016/j.ymeth.2012.01.002. Epub 2012 Jan 21.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Quantitative proteome profiling of normal human circulating microparticles.
J Proteome Res. 2012 Apr 6;11(4):2154-63. doi: 10.1021/pr200901p. Epub 2012 Mar 1.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Proteomic analysis of microvesicles in human saliva by gel electrophoresis with liquid chromatography-mass spectrometry.
Anal Chim Acta. 2012 Apr 20;723:61-7. doi: 10.1016/j.aca.2012.02.018. Epub 2012 Feb 19.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Proteomic analysis of microvesicles from plasma of healthy donors reveals high individual variability.
J Proteomics. 2012 Jun 27;75(12):3574-84. doi: 10.1016/j.jprot.2012.03.054. Epub 2012 Apr 10.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET.
Nat Med. 2012 Jun;18(6):883-91. doi: 10.1038/nm.2753.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Proteomic analysis of microvesicles from plasma of healthy donors reveals high individual variability.
J Proteomics. 2012 Jun 27;75(12):3574-84. doi: 10.1016/j.jprot.2012.03.054. Epub 2012 Apr 10.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Proteomic analysis of microvesicles from plasma of healthy donors reveals high individual variability.
J Proteomics. 2012 Jun 27;75(12):3574-84. doi: 10.1016/j.jprot.2012.03.054. Epub 2012 Apr 10.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Proteomic analysis of microvesicles from plasma of healthy donors reveals high individual variability.
J Proteomics. 2012 Jun 27;75(12):3574-84. doi: 10.1016/j.jprot.2012.03.054. Epub 2012 Apr 10.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Proteomic analysis of microvesicles from plasma of healthy donors reveals high individual variability.
J Proteomics. 2012 Jun 27;75(12):3574-84. doi: 10.1016/j.jprot.2012.03.054. Epub 2012 Apr 10.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
The proteome of erythrocyte-derived microparticles from plasma: new clues for erythrocyte aging and vesiculation.
J Proteomics. 2012 Dec 5;76 Spec No.:203-10. doi: 10.1016/j.jprot.2012.05.031. Epub 2012 Jun 2.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Biochemical and physical characterisation of urinary nanovesicles following CHAPS treatment.
PLoS One. 2012;7(7):e37279. doi: 10.1371/journal.pone.0037279. Epub 2012 Jul 12.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Biochemical and physical characterisation of urinary nanovesicles following CHAPS treatment.
PLoS One. 2012;7(7):e37279. doi: 10.1371/journal.pone.0037279. Epub 2012 Jul 12.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Medulloblastoma exosome proteomics yield functional roles for extracellular vesicles.
PLoS One. 2012;7(7):e42064. doi: 10.1371/journal.pone.0042064. Epub 2012 Jul 27.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Proteolytic Potential of the MSC Exosome Proteome: Implications for an Exosome-Mediated Delivery of Therapeutic Proteasome.
Int J Proteomics. 2012;2012:971907. doi: 10.1155/2012/971907. Epub 2012 Jul 18.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Cause or effect of arteriogenesis: compositional alterations of microparticles from CAD patients undergoing external counterpulsation therapy.
PLoS One. 2012;7(10):e46822. doi: 10.1371/journal.pone.0046822. Epub 2012 Oct 8.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Improved flow cytometric assessment reveals distinct microvesicle (cell-derived microparticle) signatures in joint diseases.
PLoS One. 2012;7(11):e49726. doi: 10.1371/journal.pone.0049726. Epub 2012 Nov 20.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Improved flow cytometric assessment reveals distinct microvesicle (cell-derived microparticle) signatures in joint diseases.
PLoS One. 2012;7(11):e49726. doi: 10.1371/journal.pone.0049726. Epub 2012 Nov 20.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Improved flow cytometric assessment reveals distinct microvesicle (cell-derived microparticle) signatures in joint diseases.
PLoS One. 2012;7(11):e49726. doi: 10.1371/journal.pone.0049726. Epub 2012 Nov 20.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Two distinct populations of exosomes are released from LIM1863 colon carcinoma cell-derived organoids.
Mol Cell Proteomics. 2013 Mar;12(3):587-98. doi: 10.1074/mcp.M112.021303. Epub 2012 Dec 10.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Two distinct populations of exosomes are released from LIM1863 colon carcinoma cell-derived organoids.
Mol Cell Proteomics. 2013 Mar;12(3):587-98. doi: 10.1074/mcp.M112.021303. Epub 2012 Dec 10.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Two distinct populations of exosomes are released from LIM1863 colon carcinoma cell-derived organoids.
Mol Cell Proteomics. 2013 Mar;12(3):587-98. doi: 10.1074/mcp.M112.021303. Epub 2012 Dec 10.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Proteomic analysis of podocyte exosome-enriched fraction from normal human urine.
J Proteomics. 2013 Apr 26;82:193-229. doi: 10.1016/j.jprot.2013.01.012. Epub 2013 Jan 30.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
A comprehensive characterization of membrane vesicles released by autophagic human endothelial cells.
Proteomics. 2013 Apr;13(7):1108-20. doi: 10.1002/pmic.201200531.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Differential protein profiling of renal cell carcinoma urinary exosomes.
Mol Biosyst. 2013 Jun;9(6):1220-33. doi: 10.1039/c3mb25582d. Epub 2013 Mar 19.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Differential protein profiling of renal cell carcinoma urinary exosomes.
Mol Biosyst. 2013 Jun;9(6):1220-33. doi: 10.1039/c3mb25582d. Epub 2013 Mar 19.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.
Proteomics. 2013 May;13(10-11):1667-71. doi: 10.1002/pmic.201200561. Epub 2013 Apr 23.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.
Proteomics. 2013 May;13(10-11):1667-71. doi: 10.1002/pmic.201200561. Epub 2013 Apr 23.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Proteome profiling of exosomes derived from human primary and metastatic colorectal cancer cells reveal differential expression of key metastatic factors and signal transduction components.
Proteomics. 2013 May;13(10-11):1672-86. doi: 10.1002/pmic.201200562.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Proteomic characterization of human platelet-derived microparticles.
Anal Chim Acta. 2013 May 7;776:57-63. doi: 10.1016/j.aca.2013.03.023. Epub 2013 Mar 19.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Heterogeneity in neutrophil microparticles reveals distinct proteome and functional properties.
Mol Cell Proteomics. 2013 Aug;12(8):2205-19. doi: 10.1074/mcp.M113.028589. Epub 2013 May 8.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Heterogeneity in neutrophil microparticles reveals distinct proteome and functional properties.
Mol Cell Proteomics. 2013 Aug;12(8):2205-19. doi: 10.1074/mcp.M113.028589. Epub 2013 May 8.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Malaria-infected erythrocyte-derived microvesicles mediate cellular communication within the parasite population and with the host immune system.
Cell Host Microbe. 2013 May 15;13(5):521-34. doi: 10.1016/j.chom.2013.04.009.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Modulation of B-cell exosome proteins by gamma herpesvirus infection.
Proc Natl Acad Sci U S A. 2013 Jul 30;110(31):E2925-33. doi: 10.1073/pnas.1303906110. Epub 2013 Jul 1.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Exosomal signaling during hypoxia mediates microvascular endothelial cell migration and vasculogenesis.
PLoS One. 2013 Jul 8;8(7):e68451. doi: 10.1371/journal.pone.0068451. Print 2013.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
LRRK2 secretion in exosomes is regulated by 14-3-3.
Hum Mol Genet. 2013 Dec 15;22(24):4988-5000. doi: 10.1093/hmg/ddt346. Epub 2013 Jul 25.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Characterization of multiple myeloma vesicles by label-free relative quantitation.
Proteomics. 2013 Oct;13(20):3013-29. doi: 10.1002/pmic.201300142.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Quantitative proteomics of extracellular vesicles derived from human primary and metastatic colorectal cancer cells.
J Extracell Vesicles. 2012 Sep 11;1. doi: 10.3402/jev.v1i0.18704. eCollection 2012.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Quantitative proteomics of extracellular vesicles derived from human primary and metastatic colorectal cancer cells.
J Extracell Vesicles. 2012 Sep 11;1. doi: 10.3402/jev.v1i0.18704. eCollection 2012.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Cellular stress conditions are reflected in the protein and RNA content of endothelial cell-derived exosomes.
J Extracell Vesicles. 2012 Apr 16;1. doi: 10.3402/jev.v1i0.18396. eCollection 2012.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Proteome profiling of neuroblastoma-derived exosomes reveal the expression of proteins potentially involved in tumor progression.
PLoS One. 2013 Sep 19;8(9):e75054. doi: 10.1371/journal.pone.0075054. eCollection 2013.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Comparative proteomics evaluation of plasma exosome isolation techniques and assessment of the stability of exosomes in normal human blood plasma.
Proteomics. 2013 Nov;13(22):3354-64. doi: 10.1002/pmic.201300282. Epub 2013 Oct 18.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Comparative proteomics evaluation of plasma exosome isolation techniques and assessment of the stability of exosomes in normal human blood plasma.
Proteomics. 2013 Nov;13(22):3354-64. doi: 10.1002/pmic.201300282. Epub 2013 Oct 18.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Diabetic nephropathy induces changes in the proteome of human urinary exosomes as revealed by label-free comparative analysis.
J Proteomics. 2014 Jan 16;96:92-102. doi: 10.1016/j.jprot.2013.10.037. Epub 2013 Nov 7.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Diabetic nephropathy induces changes in the proteome of human urinary exosomes as revealed by label-free comparative analysis.
J Proteomics. 2014 Jan 16;96:92-102. doi: 10.1016/j.jprot.2013.10.037. Epub 2013 Nov 7.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Exosomal ITGA3 interferes with non-cancerous prostate cell functions and is increased in urine exosomes of metastatic prostate cancer patients.
J Extracell Vesicles. 2013 Dec 23;2. doi: 10.3402/jev.v2i0.22097. eCollection 2013.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Exosomal ITGA3 interferes with non-cancerous prostate cell functions and is increased in urine exosomes of metastatic prostate cancer patients.
J Extracell Vesicles. 2013 Dec 23;2. doi: 10.3402/jev.v2i0.22097. eCollection 2013.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Quantitative proteomics of fractionated membrane and lumen exosome proteins from isogenic metastatic and nonmetastatic bladder cancer cells reveal differential expression of EMT factors.
Proteomics. 2014 Mar;14(6):699-712. doi: 10.1002/pmic.201300452. Epub 2014 Feb 16.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Quantitative proteomics of fractionated membrane and lumen exosome proteins from isogenic metastatic and nonmetastatic bladder cancer cells reveal differential expression of EMT factors.
Proteomics. 2014 Mar;14(6):699-712. doi: 10.1002/pmic.201300452. Epub 2014 Feb 16.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Quantitative proteomics of fractionated membrane and lumen exosome proteins from isogenic metastatic and nonmetastatic bladder cancer cells reveal differential expression of EMT factors.
Proteomics. 2014 Mar;14(6):699-712. doi: 10.1002/pmic.201300452. Epub 2014 Feb 16.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Exosomal proteins in the aqueous humor as novel biomarkers in patients with neovascular age-related macular degeneration.
J Proteome Res. 2014 Feb 7;13(2):581-95. doi: 10.1021/pr400751k. Epub 2014 Jan 16.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Exosomal proteins in the aqueous humor as novel biomarkers in patients with neovascular age-related macular degeneration.
J Proteome Res. 2014 Feb 7;13(2):581-95. doi: 10.1021/pr400751k. Epub 2014 Jan 16.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
In-depth proteomic analyses of ovarian cancer cell line exosomes reveals differential enrichment of functional categories compared to the NCI 60 proteome.
Biochem Biophys Res Commun. 2014 Mar 21;445(4):694-701. doi: 10.1016/j.bbrc.2013.12.070. Epub 2014 Jan 14.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Plasma biomarker discovery in preeclampsia using a novel differential isolation technology for circulating extracellular vesicles.
Am J Obstet Gynecol. 2014 Mar 18. pii: S0002-9378(14)00248-8. doi: 10.1016/j.ajog.2014.03.038.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Plasma biomarker discovery in preeclampsia using a novel differential isolation technology for circulating extracellular vesicles.
Am J Obstet Gynecol. 2014 Mar 18. pii: S0002-9378(14)00248-8. doi: 10.1016/j.ajog.2014.03.038.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Plasma biomarker discovery in preeclampsia using a novel differential isolation technology for circulating extracellular vesicles.
Am J Obstet Gynecol. 2014 Mar 18. pii: S0002-9378(14)00248-8. doi: 10.1016/j.ajog.2014.03.038.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Quantitative proteomics of extracellular vesicles released from human monocyte-derived macrophages upon beta-glucan stimulation.
J Proteome Res. 2014 May 2;13(5):2468-77. doi: 10.1021/pr4012552. Epub 2014 Apr 16.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Human urinary exosomes as innate immune effectors.
J Am Soc Nephrol. 2014 Sep;25(9):2017-27. doi: 10.1681/ASN.2013101066. Epub 2014 Apr 3.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
The overexpression of a single oncogene (ERBB2/HER2) alters the proteomic landscape of extracellular vesicles.
Proteomics. 2014 Jun;14(12):1472-9. doi: 10.1002/pmic.201300485. Epub 2014 May 15.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
The overexpression of a single oncogene (ERBB2/HER2) alters the proteomic landscape of extracellular vesicles.
Proteomics. 2014 Jun;14(12):1472-9. doi: 10.1002/pmic.201300485. Epub 2014 May 15.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
The overexpression of a single oncogene (ERBB2/HER2) alters the proteomic landscape of extracellular vesicles.
Proteomics. 2014 Jun;14(12):1472-9. doi: 10.1002/pmic.201300485. Epub 2014 May 15.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
The overexpression of a single oncogene (ERBB2/HER2) alters the proteomic landscape of extracellular vesicles.
Proteomics. 2014 Jun;14(12):1472-9. doi: 10.1002/pmic.201300485. Epub 2014 May 15.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Discovery of prognostic biomarker candidates of lacunar infarction by quantitative proteomics of microvesicles enriched plasma.
PLoS One. 2014 Apr 21;9(4):e94663. doi: 10.1371/journal.pone.0094663. eCollection 2014.
ENOG410Z40H
417
/
0
/
417
Serum albumin
P02768
Discovery of prognostic biomarker candidates of lacunar infarction by quantitative proteomics of microvesicles enriched plasma.
PLoS One. 2014 Apr 21;9(4):e94663. doi: 10.1371/journal.pone.0094663. eCollection 2014.
ENOG410Z40H
417
/
0
/
417
[1]
[2]
[3]
[4]